Senior Technical Research Analyst At Nirmal Bang Securities Pvt. Ltd

Jump to

Buy Aurobindo Pharma; SL Rs 157, target Rs 174: Chopra

One can buy Aurobindo Pharma with a stop-loss of Rs 157 for the target of Rs 174, says Manav Chopra, Senior Technical Research Analyst at Nirmal Bang Securities.
Hindalco Industries has support at Rs 116: Chopra

Hindalco Industries has support at Rs 116, says Manav Chopra, Senior Technical Research Analyst at Nirmal Bang Securities.
Expect Ambuja Cements to test Rs 230-235: Chopra

Manav Chopra, Senior Technical Research Analyst at Nirmal Bang Securities, is of the view that Ambuja Cements is expected to test the levels of Rs 230-235 in the near-term and Grasim Industries to test Rs 3,520 levels.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Senior Technical Research Analyst At Nirmal Bang Securities Pvt. Ltd

Buy Aurobindo Pharma; SL Rs 157, target Rs 174: Chopra

Hindalco Industries has support at Rs 116: Chopra

Expect Ambuja Cements to test Rs 230-235: Chopra